title: Polymorphisms in oxidative stress-related genes are not associated with prostate cancer risk in heavy smokers.
abstract: Oxidative stress, associated with aging and inflammation, is likely to play a role in the etiology of prostate cancer. We evaluated potential associations between gene variants that result in reduced neutralization of reactive oxygen species (ROS; MnSOD Ala-16Val, CAT -262 C>T, and GPX1 Pro200Leu) and prostate cancer risk among 724 men with incident prostate cancer who participated in the Carotene and Retinol Efficacy Trial (CARET) cohort, a randomized trial for the prevention of lung cancer among men with a history of smoking and/or asbestos exposure. Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated by logistic regression. Nested case-control analyses included study participants with available DNA (n = 533 cases and 1,470 controls), matched for race, age, and length of follow-time. Overall, there were no associations between genotypes of MnSOD, CAT, and GPX1 and prostate cancer risk, although among men diagnosed before age 65, CAT TT genotype was associated with increased risk (OR, 2.0; 95% CI, 0.97-3.95). Further analyses stratified by factors related to environmental oxidative stress exposures did not modify associations. When calculating the number of risk alleles of MnSOD, CAT, and GPX1 hypothetically related to reduced protection against ROS, there was a nonsignificant relationship between prostate cancer and carriage of five or more risk alleles, in comparison to men with less than five risk alleles (OR, 2.0; 95% CI, 0.90-4.42). In conclusion, it does not seem that variants in MnSOD, CAT, or GPX1 have an influence on prostate cancer risk in this cohort of men who were smokers or exposed to asbestos, although it is possible that cumulative defects in protection from oxidative stress may result in increased risk of the disease.
authors.affiliation: Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Elm and Carlton Sts., Buffalo, NY 14263, USA. ji-yeob.choi@roswellpark.org
authors.forename: Ji-Yeob
authors.initials: JY
authors.lastname: Choi
authors.forename: Marian L
authors.initials: ML
authors.lastname: Neuhouser
authors.forename: Matt
authors.initials: M
authors.lastname: Barnett
authors.forename: Matthew
authors.initials: M
authors.lastname: Hudson
authors.forename: Alan R
authors.initials: AR
authors.lastname: Kristal
authors.forename: Mark
authors.initials: M
authors.lastname: Thornquist
authors.forename: Irena B
authors.initials: IB
authors.lastname: King
authors.forename: Gary E
authors.initials: GE
authors.lastname: Goodman
authors.forename: Christine B
authors.initials: CB
authors.lastname: Ambrosone
mesh_terms: D017668:Age of Onset; D001194:Asbestos / Q000009:adverse effects; D016022:Case-Control Studies; D002374:Catalase / Q000235:genetics; D004311:Double-Blind Method; D020022:Genetic Predisposition to Disease; D005979:Glutathione Peroxidase / Q000235:genetics; D006801:Humans; D008297:Male; D016273:Occupational Exposure / Q000009:adverse effects; D018384:Oxidative Stress / Q000235:genetics*; D011110:Polymorphism, Genetic; D011471:Prostatic Neoplasms / Q000235:genetics*; D012907:Smoking / Q000009:adverse effects*; D013482:Superoxide Dismutase / Q000235:genetics
chemical_list: D001194:Asbestos; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase